Founded Year

2014

Stage

Series B | Alive

Total Raised

$31.08M

Last Raised

$18.35M | 10 mos ago

About Cyrus Biotechnology

Cyrus Biotechnology offers advanced software tools for protein modeling and engineering to customers in Biotech, Pharma, Consumer Products, Chemicals, and Synthetic Biology. It is based in Seattle, Washington.

Cyrus Biotechnology Headquarter Location

1201 Second Ave Suite 900

Seattle, Washington, 98101,

United States

206-258-6561

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Cyrus Biotechnology's Products & Differentiation

See Cyrus Biotechnology's products and how their products differentiate from alternatives and competitors

  • ACE2.v2

    Pre-clinical stage COVID biologic therapeutic.

    Differentiation

    Broader therapeutic coverage of COVID variants than known mAbs 

Expert Collections containing Cyrus Biotechnology

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Cyrus Biotechnology is included in 3 Expert Collections, including Synthetic Biology.

S

Synthetic Biology

67 items

Synthetic biology focused on replacing industrial and commercial materials.

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

D

Digital Health

12,795 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

Latest Cyrus Biotechnology News

Funding News: Enzyme design startup lands $33M; addiction recovery company raises $3M

Mar 31, 2022

Funding News: Enzyme design startup lands $33M; addiction recovery company raises $3M March 31, 2022 at 9:09 am Share Inside Arzeda’s labs in Seattle. (GeekWire Photo / James Thorne) — Protein design company Arzeda raised close to $33 million, the Seattle startup announced Wednesday . The company generates new enzymes for industrial, agricultural and other applications. Arzeda creates blueprints for enzymes using protein design software spun out of the lab of David Baker, head of the University of Washington’s Institute for Protein Design. Arzeda also tests and develops the enzymes in its labs in the city’s South Lake Union neighborhood; GeekWire took a tour a few years ago. Arzeda recently inked a partnership with Unilever to discover new enzymes for cleaning and laundry products. It also partners with oil giant BP, and develops enzymes involved in fermentation with biotech company Amyris. CEO and VP of research Alexandre Zanghelli co-founded Arzeda in 2009, the same year he earned his Ph.D. in Baker’s lab. Arzeda is one of several protein engineering startups founded on research from the lab, including A-Alpha Bio, Cyrus Biotechnology and vaccine company Icosavax. The Series B funding round was led by Conti Ventures, the venture arm of Continental Grain Company, and included new investors Lewis & Clark Agrifood, Bunge Ventures, the venture capital arm of agribusiness company Bunge, and Circulate Capital. Previous investors participating in the funding round include OS Fund, Casdin Capital, UMI and Bioeconomy Capital. Arzeda had previously raised $15.2 million in its Series A round and follow-on funding in 2017. The new funding will enable the company to further develop and commercialize its portfolio of enzymes. WeConnect co-founders Murphy Jensen and Daniela Luzi Tudor. (WeConnect Photos) —  WEconnect Health Management raised $3 million to help people with substance abuse disorder. The Seattle startup’s healthcare products include an app that provides recovery techniques to reduce relapse and enables people to join support meetings, track progress, and schedule “healthy routines.” Over the last year the company has launched a free version of the app, tallied more than 750,000 participants in its mobile recovery meetings, and signed up healthcare partners Molina Healthcare of California and Be Well Texas. WEConnect employs more than 42 people. The latest round of funding, from current investors, builds on a $6 million Series A round in 2018. That round included Fred Luddy, the billionaire founder of tech giant ServiceNow, and several other high net worth backers. Charlotte Schubert is a GeekWire reporter and science journalist with a focus on biotech, healthcare, and life sciences. She is a Seattle native, former editor at Nature Medicine, and recovering lab rat. Follow her on Twitter at @schubertcm or reach her at charlotte@geekwire.com . Share

Cyrus Biotechnology Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Cyrus Biotechnology Rank

You May Also Like

Redesign Science Logo
Redesign Science

Redesign Science is a computational chemistry company that engages in early-stage, small molecule drug discovery. The company efficiently simulates protein targets at the atomic level to reveal hidden, subtle drug opportunities that fall outside the capability, and scope of alternative computational models.

Cambridge Consultants Logo
Cambridge Consultants

Cambridge Consultants leads the way in innovative product development. The company is the development partner of choice to many of the world's leading blue chips, as well as the virtual development team for ambitious start-up companies.

Citrine Informatics Logo
Citrine Informatics

Citrine Informatics provides AI-powered materials informatics. Citrine's machine learning-based platform mines vast quantities of data about materials, chemicals, and processes to help users hit their R&D and manufacturing targets in half the time.

XtalPi Logo
XtalPi

XtalPi is a cloud-based technology company that solves drug polymorphism by providing accurate computational crystal structure prediction for small-molecule drugs.

Fractal Analytics Logo
Fractal Analytics

Fractal Analytics is a global analytics firm that helps companies gain competitive advantage through deep understanding of consumers and better data-driven decisions. Fractal Analytics delivers insight and impact through advanced analytics, deep learning and visual storytelling.

InstaDeep Logo
InstaDeep

InstaDeep offers a host of AI solutions, ranging from optimized pattern recognition and GPU-accelerated insights to self-learning decision making systems.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.